Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Syndax to present entinostat data against cancer at AACR meeting

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced 11 posters on entinostat, an oral, highly selective, class I histone deacetylase inhibitor, will be presented at the 102nd Annual American Association for Cancer Research meeting April 2 to April 6 in Orlando, FL.

1 Apr 2011

Study finds continued smoking after cancer diagnosis among patients, family caregivers

Nicotine is so addictive for many people that even a cancer diagnosis doesn't help them - or their family members and caregivers - throw the cigarettes away.

31 Mar 2011

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

On Capitol Hill today, colorectal cancer experts and advocates will gather to promote the establishment of a national colorectal cancer screening program in an effort to save lives.

From Evident Corporation - Life Sciences 31 Mar 2011

Amgen appeals EMA CHMP negative opinion on Vectibix-chemotherapy combination for wild-type KRAS mCRC

Amgen announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in March by the Committee For Medicinal Products for Human Use (CHMP) for the use of Vectibix in combination with chemotherapy for patients with wild-type KRAS metastatic colorectal cancer (mCRC).

31 Mar 2011

CCAC National Survey finds 82% of Canadians with cancer

The Colorectal Cancer Association of Canada today announced findings from the Weighing Quality of Life in Cancer National Survey showing that an alarming 82 per cent of Canadians have been touched closely by cancer and have had a close friend or family member battle cancer, or have done so themselves.

31 Mar 2011

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

The simple practice of letters and a telephone call to patients who are due for a colonoscopy significantly improves adherence to endoscopic follow-up recommendations, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

30 Mar 2011

Merck submits Erbitux indication extension to EMA for NSCLC treatment

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an indication extension to the European Medicines Agency for the approval of Erbitux in combination with standard 1st line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer with high epidermal growth factor receptor expression.

30 Mar 2011

SHMT1 gene and folate deficiency increase risk for colon cancer

Offering a likely insight into how such cancers develop in humans - Cornell University researchers report they have identified a gene that increases the risk for colon cancer in laboratory mice when the animals' diets are deficient in folate.

30 Mar 2011

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer

Interventional radiologists have been the leaders in the use of intra-arterial yttrium-90 radioembolization, since its introduction in 2000, to treat liver cancer.

29 Mar 2011

Keryx KRX-0401 trial data against colorectal cancer, multiple myeloma to be presented at AACR

Keryx Biopharmaceuticals, Inc. today announced that two abstracts on KRX-0401 will be presented at the upcoming 102nd annual meeting of the American Association for Cancer Research to be held in Orlando, Florida, from April 2-6, 2011.

29 Mar 2011

Everist Genomics announces global launch of OncoDefender-CRC colorectal cancer assay

Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor.

28 Mar 2011

APP voluntarily recalls Irinotecan Hydrochloride Injection for precautionary measure

APP Pharmaceuticals, Inc., announced today that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectal cancer.

28 Mar 2011

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor, a cholesterol-lowering drug, can prevent new colon tumors from forming after colon cancer surgery.

25 Mar 2011

Early diagnosis of colorectal cancer can minimize treatment side effects in survivors

Renato Lenzi, M.D., medical oncologist at The University of Texas MD Anderson Cancer Center and colon cancer survivor, knows only too well how important preventive methods are to beating colorectal cancer. After all, a routine colonoscopy saved his life.

24 Mar 2011

Jefferson begins patient recruitment for new clinical trail to prevent colon cancer

Thomas Jefferson University has started recruiting patients for a new National Cancer Institute-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer.

23 Mar 2011

Bowel cancer incidence set to rise: Research

According to the latest research from the Cancer Council, the incidence of bowel cancer in Australia is set to rise to 21,000 cases a year in the next decade. The report shows that one in five cases are diagnosed at an advanced stage, due to a lack of screening. This research is being used to renew the Federal Government’s full funding and implementation of the national bowel cancer screening program. Funding for the program is due to expire at the end of June.

21 Mar 2011

Abbott receives CE-Mark for new qualitative PCR-based HIV-1 test

Abbott (NYSE: ABT) announced today that it has received CE-Mark for a new qualitative PCR-based HIV-1 test that produces highly accurate results from dried blood spot and plasma specimens. The new assay is a long-awaited diagnostic tool for health officials in African nations and other resource-limited areas to detect HIV-1 infected infants at early stages and begin treatment when success is more likely.

21 Mar 2011

Researchers discover 'broad spectrum' cancer suppressor gene

Portuguese researchers have discovered a "broad spectrum" cancer suppressor gene - called LRP1B - which acts by removing proteins crucial for cancer development from the tumour environment. The fact that LRP1B does not act on the tumour itself (in this study thyroid tumours) but, instead, on molecules which are known to be important to many different cancers is what makes it so interesting.

21 Mar 2011

Research roundup: Successful medical homes; shortage of HIV doctors; boosting use of $4 generic drugs

Every Friday, Jennifer Evans compiles this selection of recently-released health policy studies and briefs.

19 Mar 2011

EMA CHMP adopts negative opinion for Amgen's Vectibix in treatment of wild-type KRAS metastatic colorectal cancer

Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen's application to extend the marketing authorization in Europe for Vectibix® (panitumumab) to include combination with chemotherapy for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC).

18 Mar 2011

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Syndax to present entinostat data against cancer at AACR meeting

Study finds continued smoking after cancer diagnosis among patients, family caregivers

Experts discuss about need for national colorectal cancer screening program at Capitol Hill

Amgen appeals EMA CHMP negative opinion on Vectibix-chemotherapy combination for wild-type KRAS mCRC

CCAC National Survey finds 82% of Canadians with cancer

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

Merck submits Erbitux indication extension to EMA for NSCLC treatment

SHMT1 gene and folate deficiency increase risk for colon cancer

Study: Y-90 radioembolization is a safe treatment for patients with liver cancer

Keryx KRX-0401 trial data against colorectal cancer, multiple myeloma to be presented at AACR

Everist Genomics announces global launch of OncoDefender-CRC colorectal cancer assay

APP voluntarily recalls Irinotecan Hydrochloride Injection for precautionary measure

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

Early diagnosis of colorectal cancer can minimize treatment side effects in survivors

Jefferson begins patient recruitment for new clinical trail to prevent colon cancer

Bowel cancer incidence set to rise: Research

Abbott receives CE-Mark for new qualitative PCR-based HIV-1 test

Researchers discover 'broad spectrum' cancer suppressor gene

Research roundup: Successful medical homes; shortage of HIV doctors; boosting use of $4 generic drugs

EMA CHMP adopts negative opinion for Amgen's Vectibix in treatment of wild-type KRAS metastatic colorectal cancer

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in